Lyons, France

Els Verhoeyen

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Lyons, FR (2013 - 2017)
  • Nice, FR (2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Els Verhoeyen

Introduction

Els Verhoeyen is a prominent inventor based in Lyons, France. She has made significant contributions to the field of biotechnology, particularly in the development of novel gene therapy techniques. With a total of five patents to her name, her work has the potential to impact various medical applications.

Latest Patents

One of her latest patents is titled "Lentiviral vector expressing membrane-anchored or secreted antibody." This invention involves a multicistronic nucleic acid that enables the co-expression of sequences into separate proteins, which can be crucial for therapeutic applications. Another notable patent is "Nipah virus envelope glycoprotein pseudotyped lentivirus." This invention relates to engineered retrovirus-like particles that can selectively modulate the activity of specific immune cells, making them particularly useful for gene therapy and vaccination.

Career Highlights

Throughout her career, Els Verhoeyen has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the École Normale Supérieure de Lyon. Her research has focused on advancing the understanding and application of viral vectors in medicine.

Collaborations

Els has collaborated with notable professionals in her field, including François-Loïc Cosset. These collaborations have further enriched her research and contributed to her innovative patents.

Conclusion

Els Verhoeyen's work exemplifies the intersection of innovation and biotechnology. Her patents reflect a commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…